| 2023-12-28 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Development Officer | 17,421 0.006% | $14.52 | $252,902 | -20.23% | |
| 2023-12-20 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Development Officer | 1,654 0.0006% | $13.10 | $21,667 | -9.98% | |
| 2023-12-19 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Development Officer | 17,500 0.006% | $13.25 | $231,875 | -11.6% | |
| 2015-06-22 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Program Management | 37,962 0.038% | $13.94 | $529,255 | -41.74% | |
| 2015-06-15 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Program Management | 14,754 0.0149% | $14.17 | $209,064 | -41.07% | |
| 2015-06-08 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Program Management | 34,624 0.0341% | $12.87 | $445,611 | -33.46% | |
| 2015-05-11 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Program Management | 20,000 0.0201% | $10.84 | $216,742 | -10.41% | |
| 2015-04-01 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 18,978 0.0185% | $10.69 | $202,960 | -3.18% | |
| 2015-01-05 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 9,334 0.008% | $7.16 | $66,855 | +22.92% | |
| 2014-11-25 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 16,206 0.0158% | $5.76 | $93,428 | +35.35% | |
| 2014-11-25 | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 16,206 0.0158% | $5.76 | $93,428 | +35.35% | ||
| 2014-10-03 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 17,104 0.0231% | $7.00 | $119,728 | +53.08% | |
| 2014-10-03 | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 17,104 0.0231% | $7.00 | $119,728 | +53.08% | ||
| 2014-10-02 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 20,416 0.0178% | $4.26 | $87,027 | +62.58% | |
| 2014-10-02 | Amicus Therapeutics, Inc. FOLD | VP, Program Management | 20,416 0.0178% | $4.26 | $87,027 | +62.58% |